Clinical trial
A Phase IIIB/IV Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets vs. Amoxicillin-Clavulanate for the Treatment of Subjects With Acute Bacterial Sinusitis
NCT00644553 is registered in ClinicalTrials.gov with Abbott as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase IIIB/IV Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets vs. Amoxicillin-Clavulanate for the Treatment of Subjects With Acute Bacterial Sinusitis
- Lead sponsor
- Abbott
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2003
- Completion date
- Not reported
- Enrollment
- 437 (actual)
- Sites
- 53
Conditions
As the registry lists them; a condition with its own page is linked.
acute bacterial sinusitis (abs)